In summary, these data demonstrate that N‐Myc regulates DDX21 expression and DDX21 regulates CEP55 expression in human neuroblastoma (Fig. 7) and that high DDX21 and high CEP55 expressions are independent prognostic markers of poor outcome in human neuroblastoma patients. This evidence concerns the gene MYCN and neuroblastoma.